A key edge Radx’s nanobodies is they can be used with gelofusine to completely eliminate kidney retention of Lu-177 and that’s a major edge compared to peptides and monoclonal antibodies
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.003(8.82%) |
Mkt cap ! $73.31M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.1¢ | $58.95K | 1.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 783888 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 870662 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| RAD (ASX) Chart |